|
|
 Previous Article | Table of Contents | Next Article 
Blood, Vol. 95 No. 9 (May 1), 2000:
pp. 2780-2785
Linkage analysis demonstrates that the prothrombin
G20210A mutation jointly influences plasma prothrombin
levels and risk of thrombosis
José Manuel Soria,
Laura Almasy,
Juan Carlos Souto,
Isabel Tirado,
Montserrat Borell,
José Mateo,
Susan Slifer,
William Stone,
John Blangero, and
Jordi Fontcuberta
From the Unitat d'Hemostàsia i Trombosi. Hospital de la Santa
Creu i Sant Pau, Barcelona, Spain; the Department of Genetics,
Southwest Foundation for Biomedical Research, San Antonio, TX; and the
Department of Biology, Trinity University, San Antonio, TX.
Association studies suggest that the G20210A mutation (G to A
substitution at nucleotide position 20210) in the prothrombin gene
(PT) is associated with increased plasma prothrombin activity and with increased risk for venous thromboembolism. To test directly for linkage between this PT variant and plasma prothrombin
activity we performed a family-based study. The G20210A genotypes and
plasma prothrombin activity levels were determined in 435 individuals belonging to 22 extended Spanish families. The sample was composed of
388 homozygous (G/G) normal individuals and 43 heterozygote (G/A) and 4 homozygote (A/A) carriers for the G20210A
mutation. The results of variance-component linkage analysis yielded a
highly significant lod score of 3.6 (P = 2.4 × 10 5) between this mutation
and a quantitative trait locus (QTL) that influences prothrombin
activity. Importantly, a conditional linkage analysis that
simultaneously accounted for association with the G20210A variant
completely eliminated the linkage signal, which indicates that this
mutation affects the function of the prothrombin gene. Additionally, a
bivariate linkage analysis of plasma prothrombin activity and
thrombosis significantly improved the linkage signal for prothrombin
activity (lod score = 4.7;
P = 1.5 × 106) and provided strong
evidence that this QTL has a pleiotropic effect on the risk of
thrombosis (lod score = 2.43; P = .0004). These results
represent the first direct genetic evidence that a QTL in the
PT gene influences prothrombin activity levels and susceptibility to thrombosis and strongly support the conclusion that
G20210A is a functional polymorphism.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
B. Dolek, S. Eraslan, S. Eroglu, B. E. Kesim, T. Ulutin, A. Yalciner, Y. R. Laleli, and N. Gozukirmizi
Molecular Analysis of Factor V Leiden, Factor V Hong Kong, Factor II G20210A, Methylenetetrahydrofolate Reductase C677T, and A1298C Mutations Related to Turkish Thrombosis Patients
Clinical and Applied Thrombosis/Hemostasis,
October 1, 2007;
13(4):
435 - 438.
[Abstract]
[PDF]
|
|
|
|
|
|
|
K. R. Viel, D. K. Machiah, D. M. Warren, M. Khachidze, A. Buil, K. Fernstrom, J. C. Souto, J. M. Peralta, T. Smith, J. Blangero, et al.
A sequence variation scan of the coagulation factor VIII (FVIII) structural gene and associations with plasma FVIII activity levels
Blood,
May 1, 2007;
109(9):
3713 - 3724.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. A. Hindorff, B. M. Psaty, C. S. Carlson, S. R. Heckbert, T. Lumley, N. L. Smith, R. N. Lemaitre, M. J. Rieder, D. A. Nickerson, and A. P. Reiner
Common Genetic Variation in the Prothrombin Gene, Hormone Therapy, and Incident Nonfatal Myocardial Infarction in Postmenopausal Women
Am. J. Epidemiol.,
April 1, 2006;
163(7):
600 - 607.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. M. Soria, L. Almasy, J. C. Souto, A. Buil, M. Lathrop, J. Blangero, and J. Fontcuberta
A Genome Search for Genetic Determinants That Influence Plasma Fibrinogen Levels
Arterioscler. Thromb. Vasc. Biol.,
June 1, 2005;
25(6):
1287 - 1292.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Sachchithananthan, S. J. Stasinopoulos, J. Wilusz, and R. L. Medcalf
The relationship between the prothrombin upstream sequence element and the G20210A polymorphism: the influence of a competitive environment for mRNA 3'-end formation
Nucleic Acids Res.,
February 17, 2005;
33(3):
1010 - 1020.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Danckwardt, N. H. Gehring, G. Neu-Yilik, P. Hundsdoerfer, M. Pforsich, U. Frede, M. W. Hentze, and A. E. Kulozik
The prothrombin 3'end formation signal reveals a unique architecture that is sensitive to thrombophilic gain-of-function mutations
Blood,
July 15, 2004;
104(2):
428 - 435.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Yuan, G. Chen, Y. Chen, C. Rotimi, and G. E. Bonney
Identifying the Susceptibility Gene(s) in a Set of Trait-Linked Genes Using Genotype Data
Genetics,
July 1, 2004;
167(3):
1445 - 1459.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. von Ahsen and M. Oellerich
The intronic prothrombin 19911A>G polymorphism influences splicing efficiency and modulates effects of the 20210G>A polymorphism on mRNA amount and expression in a stable reporter gene assay system
Blood,
January 15, 2004;
103(2):
586 - 593.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J Esparza-Gordillo, J M Soria, A Buil, J C Souto, L Almasy, J Blangero, S R de Cordoba, and J Fontcuberta
Genetic correlation between plasma levels of C4BP isoforms containing {beta} chains and susceptibility to thrombosis
J. Med. Genet.,
January 1, 2004;
41(1):
e5 - 5.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. D. McBane II
Genetically Determined Procoagulant States and Heparin Use
Seminars in Cardiothoracic and Vascular Anesthesia,
December 1, 2003;
7(4):
427 - 442.
[Abstract]
[PDF]
|
|
|
|
|
|
|
N. Ertekin-Taner, J. Ronald, H. Asahara, L. Younkin, M. Hella, S. Jain, E. Gnida, S. Younkin, D. Fadale, Y. Ohyagi, et al.
Fine mapping of the {alpha}-T catenin gene to a quantitative trait locus on chromosome 10 in late-onset Alzheimer's disease pedigrees
Hum. Mol. Genet.,
December 1, 2003;
12(23):
3133 - 3143.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Santamaria, A. Oliver, M. Borrell, J. Mateo, R. Belvis, J. Marti-Fabregas, R. Ortin;, I. Tirado, J.C. Souto, and J. Fontcuberta
Risk of Ischemic Stroke Associated With Functional Thrombin-Activatable Fibrinolysis Inhibitor Plasma Levels
Stroke,
October 1, 2003;
34(10):
2387 - 2391.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. M. Soria, L. Almasy, J. C. Souto, A. Buil, E. Martinez-Sanchez, J. Mateo, M. Borrell, W. H. Stone, M. Lathrop, J. Fontcuberta, et al.
A new locus on chromosome 18 that influences normal variation in activated protein C resistance phenotype and factor VIII activity and its relation to thrombosis susceptibility
Blood,
January 1, 2003;
101(1):
163 - 167.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Almasy and J.W. MacCluer
Association Studies of Vascular Phenotypes: How and Why?
Arterioscler. Thromb. Vasc. Biol.,
July 1, 2002;
22(7):
1055 - 1057.
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. S. Pollak, H.-S. Lam, and J. E. Russell
The G20210A mutation does not affect the stability of prothrombin mRNA in vivo
Blood,
June 17, 2002;
100(1):
359 - 362.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Russo, D. Girelli, O. Olivieri, P. Guarini, F. Manzato, F. Pizzolo, B. Zaia, A. Mazzucco, and R. Corrocher
G20210A Prothrombin Gene Polymorphism and Prothrombin Activity in Subjects With or Without Angiographically Documented Coronary Artery Disease
Circulation,
May 22, 2001;
103(20):
2436 - 2440.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
